An Open Label, 4-week, Randomised, Multi-Centre, Phase IV Study to Compare the Efficacy and Safety of Quetiapine Fumarate (SeroquelTM) as Mono-Therapy or adjunct to lithium in the treatment of patients with acute mania in bipolar disorder